Tae Y. Kim
Cheonan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 295 publications
Prognostic Significance of Detectable Antithyroglobulin Antibodies Based on Analytical Sensitivity in Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin after Radioactive Iodine Treatment.
Journal: Thyroid : official journal of the American Thyroid Association
Published: June 01, 2026
Dependence of catalytic properties of strongly supported platinum clusters with atom counts.
Journal: Science (New York, N.Y.)
Published: May 28, 2026
Hierarchical ceria nanoarchitecture enabling accelerated lattice oxygen activation for efficient redox reactions.
Journal: Nature communications
Published: December 29, 2025
Pathology-guided enrichment of targetable gene rearrangements in BRAF wild-type papillary thyroid carcinoma.
Journal: Scientific reports
Published: November 04, 2025
Pathology-guided enrichment of targetable gene rearrangements in BRAF wild-type papillary thyroid carcinoma.
Journal: Scientific reports
Published: November 04, 2025
Observation of tWZ Production at the CMS Experiment.
Journal: Physical review letters
Published: October 21, 2025
Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.
Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.
Journal: Physical review letters
Published: October 10, 2025
Simultaneous Probe of the Charm and Bottom Quark Yukawa Couplings Using tt[over ¯]H Events.
Journal: Physical review letters
Published: September 26, 2025
Unstimulated Highly Sensitive Thyroglobulin <0.2 ng/mL: Insufficient to Predict Stimulated Thyroglobulin <1 ng/mL?
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: September 18, 2025
Surface Modification of Cranioplasty Implants to Reduce Postoperative Cerebrospinal Fluid Collection: A Preliminary Clinical Study.
Journal: Korean journal of neurotrauma
Published: September 08, 2025
OPTIMAL: a multinational phase III study of oral paclitaxel (DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 26, 2025
Last Updated: 09/26/2026